Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06647732
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-16
Brief Title:
Zanubrutinib Plus Rituximab As Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma MALT
Sponsor:
Organization:
None